Lacosamide Adroiq Europese Unie - Nederlands - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lacosamide - epilepsie - van anti-epileptica, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide hameln 10 mg/ml oplossing voor infusie Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

lacosamide hameln 10 mg/ml oplossing voor infusie

lacosamide 10 mg/ml - oplossing voor infusie - natriumchloride ; water voor injectie ; zoutzuur (e 507)